BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11420462)

  • 1. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization.
    Erickson LA; Jalal SM; Goellner JR; Law ME; Harwood A; Jin L; Roche PC; Lloyd RV
    Am J Surg Pathol; 2001 Jul; 25(7):911-7. PubMed ID: 11420462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization.
    Erickson LA; Jalal SM; Harwood A; Shearer B; Jin L; Lloyd RV
    Am J Surg Pathol; 2004 May; 28(5):578-84. PubMed ID: 15105644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
    Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
    Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
    Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
    Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
    Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of numerical chromosome anomalies in interphase cells of benign and malignant thyroid lesions using fluorescence in situ hybridization.
    Barril N; Carvalho-Sales AB; Tajara EH
    Cancer Genet Cytogenet; 2000 Feb; 117(1):50-6. PubMed ID: 10700867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
    Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
    J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization.
    Frisk T; Kytölä S; Wallin G; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 1999 Aug; 25(4):349-53. PubMed ID: 10398428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience in Hurthle cell tumors].
    Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
    G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of numerical chromosomal aberrations in adrenal cortical neoplasms by fluorescence in situ hybridization.
    Shono T; Sakai H; Takehara K; Honda S; Kanetake H
    J Urol; 2002 Oct; 168(4 Pt 1):1370-3. PubMed ID: 12352395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.
    Hemmer S; Wasenius VM; Knuutila S; Joensuu H; Franssila K
    Br J Cancer; 1998 Oct; 78(8):1012-7. PubMed ID: 9792143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
    Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid.
    Bronner MP; Clevenger CV; Edmonds PR; Lowell DM; McFarland MM; LiVolsi VA
    Am J Clin Pathol; 1988 Jun; 89(6):764-9. PubMed ID: 3369368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.